Idexx Laboratories (IDXX) EPS (Diluted) (2009 - 2026)
Idexx Laboratories (IDXX) reported EPS (Diluted) of $4.01 for Q3 2026, up 17.9% from $3.40 a year earlier but down 6.0% from the prior quarter.
Powered by 
Analysis
Idexx Laboratories (IDXX) EPS (Diluted) (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Idexx Laboratories' EPS (Diluted) came in at $14.96, up 17.4% year-over-year; for FY2025, it came in at $13.08, up 22.6% from FY2024.
- EPS (Diluted) has increased for three consecutive years, with a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
- By year, EPS (Diluted) came in at $10.67 in FY2024 (+6.0%), $10.06 in FY2023 (+25.4%), $8.03 in FY2022 (-6.7%) and $8.60 in FY2021 (+28.3%).
- Five-year quarterly EPS (Diluted) spans a low of $1.56 in Q2 2022 and a high of $4.27 in Q2 2026.
- Year over year, EPS (Diluted) has now increased in each of the last nine quarters, with growth averaging 19.8% over the last eight quarters.
- The high point for year-over-year EPS (Diluted) in five years was Q2 2023 (growth of 71.7%); the low point was Q2 2022 (a decline of 33.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $4.27 (Q2 2026), $3.47 (Q1 2026) and $3.06 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 0.56 |
| 10 | Idexx Laboratories | 53.33 Bn | 52.56 Bn | 764.30 Mn | 4.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.01 |
| Jun 30, 2026 | 4.27 |
| Mar 31, 2026 | 3.47 |
| Dec 31, 2025 | 3.06 |
| Sep 30, 2025 | 3.40 |
| Jun 30, 2025 | 3.63 |
| Mar 31, 2025 | 2.96 |
| Dec 31, 2024 | 2.60 |
| Sep 30, 2024 | 2.80 |
| Jun 30, 2024 | 2.44 |
| Mar 31, 2024 | 2.81 |
| Dec 31, 2023 | 2.32 |
| Sep 30, 2023 | 2.53 |
| Jun 30, 2023 | 2.67 |
| Mar 31, 2023 | 2.55 |
| Dec 31, 2022 | 2.04 |
| Sep 30, 2022 | 2.15 |
| Jun 30, 2022 | 1.56 |
| Mar 31, 2022 | 2.27 |
| Dec 31, 2021 | 1.88 |
API Access
Idexx Laboratories EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=IDXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();